These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33471039)

  • 1. Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial.
    Gudbergsen H; Overgaard A; Henriksen M; Wæhrens EE; Bliddal H; Christensen R; Nielsen SM; Boesen M; Knop FK; Astrup A; Rasmussen MU; Bartholdy C; Daugaard CL; Ellegaard K; Heitmann BL; Bartels EM; Danneskiold-Samsøe B; Kristensen LE
    Am J Clin Nutr; 2021 Feb; 113(2):314-323. PubMed ID: 33471039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of liraglutide on body weight and pain in patients with overweight and knee osteoarthritis: protocol for a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial.
    Gudbergsen H; Henriksen M; Wæhrens EE; Overgaard A; Bliddal H; Christensen R; Boesen MP; Knop FKK; Astrup A; Rasmussen MU; Bartholdy C; Daugaard C; Bartels EM; Ellegaard K; Heitmann BL; Kristensen LE
    BMJ Open; 2019 May; 9(5):e024065. PubMed ID: 31061017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
    Davies MJ; Bergenstal R; Bode B; Kushner RF; Lewin A; Skjøth TV; Andreasen AH; Jensen CB; DeFronzo RA;
    JAMA; 2015 Aug; 314(7):687-99. PubMed ID: 26284720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
    Pi-Sunyer X; Astrup A; Fujioka K; Greenway F; Halpern A; Krempf M; Lau DC; le Roux CW; Violante Ortiz R; Jensen CB; Wilding JP;
    N Engl J Med; 2015 Jul; 373(1):11-22. PubMed ID: 26132939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
    Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial.
    Halawi H; Khemani D; Eckert D; O'Neill J; Kadouh H; Grothe K; Clark MM; Burton DD; Vella A; Acosta A; Zinsmeister AR; Camilleri M
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):890-899. PubMed ID: 28958851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.
    Lundgren JR; Janus C; Jensen SBK; Juhl CR; Olsen LM; Christensen RM; Svane MS; Bandholm T; Bojsen-Møller KN; Blond MB; Jensen JB; Stallknecht BM; Holst JJ; Madsbad S; Torekov SS
    N Engl J Med; 2021 May; 384(18):1719-1730. PubMed ID: 33951361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomized controlled trial.
    Andersen E; Juhl CR; Kjøller ET; Lundgren JR; Janus C; Dehestani Y; Saupstad M; Ingerslev LR; Duun OM; Jensen SBK; Holst JJ; Stallknecht BM; Madsbad S; Torekov SS; Barrès R
    Hum Reprod; 2022 Jun; 37(7):1414-1422. PubMed ID: 35580859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
    O'Neil PM; Birkenfeld AL; McGowan B; Mosenzon O; Pedersen SD; Wharton S; Carson CG; Jepsen CH; Kabisch M; Wilding JPH
    Lancet; 2018 Aug; 392(10148):637-649. PubMed ID: 30122305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial.
    Blackman A; Foster GD; Zammit G; Rosenberg R; Aronne L; Wadden T; Claudius B; Jensen CB; Mignot E
    Int J Obes (Lond); 2016 Aug; 40(8):1310-9. PubMed ID: 27005405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Diet and Exercise on Knee Pain in Patients With Osteoarthritis and Overweight or Obesity: A Randomized Clinical Trial.
    Messier SP; Beavers DP; Queen K; Mihalko SL; Miller GD; Losina E; Katz JN; Loeser RF; DeVita P; Hunter DJ; Newman JJ; Quandt SA; Lyles MF; Jordan JM; Callahan LF
    JAMA; 2022 Dec; 328(22):2242-2251. PubMed ID: 36511925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
    le Roux CW; Astrup A; Fujioka K; Greenway F; Lau DCW; Van Gaal L; Ortiz RV; Wilding JPH; Skjøth TV; Manning LS; Pi-Sunyer X;
    Lancet; 2017 Apr; 389(10077):1399-1409. PubMed ID: 28237263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.
    Lau DCW; Erichsen L; Francisco AM; Satylganova A; le Roux CW; McGowan B; Pedersen SD; Pietiläinen KH; Rubino D; Batterham RL
    Lancet; 2021 Dec; 398(10317):2160-2172. PubMed ID: 34798060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study.
    Kim SH; Liu A; Ariel D; Abbasi F; Lamendola C; Grove K; Tomasso V; Reaven G
    Diabetologia; 2014 Mar; 57(3):455-62. PubMed ID: 24326527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term weight-loss maintenance in obese patients with knee osteoarthritis: a randomized trial.
    Christensen P; Henriksen M; Bartels EM; Leeds AR; Meinert Larsen T; Gudbergsen H; Riecke BF; Astrup A; Heitmann BL; Boesen M; Christensen R; Bliddal H
    Am J Clin Nutr; 2017 Sep; 106(3):755-763. PubMed ID: 28747328
    [No Abstract]   [Full Text] [Related]  

  • 16. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.
    Kelly AS; Auerbach P; Barrientos-Perez M; Gies I; Hale PM; Marcus C; Mastrandrea LD; Prabhu N; Arslanian S;
    N Engl J Med; 2020 May; 382(22):2117-2128. PubMed ID: 32233338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study.
    Wadden TA; Hollander P; Klein S; Niswender K; Woo V; Hale PM; Aronne L;
    Int J Obes (Lond); 2013 Nov; 37(11):1443-51. PubMed ID: 23812094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in physical activity during a one-year weight loss trial with liraglutide vs placebo in participants with knee osteoarthritis: Secondary analyses of a randomised controlled trial.
    Bartholdy C; Overgaard A; Gudbergsen H; Bliddal H; Kristensen LE; Henriksen M
    Osteoarthr Cartil Open; 2022 Jun; 4(2):100255. PubMed ID: 36475294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial.
    Neeland IJ; Marso SP; Ayers CR; Lewis B; Oslica R; Francis W; Rodder S; Pandey A; Joshi PH
    Lancet Diabetes Endocrinol; 2021 Sep; 9(9):595-605. PubMed ID: 34358471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total knee replacement plus physical and medical therapy or treatment with physical and medical therapy alone: a randomised controlled trial in patients with knee osteoarthritis (the MEDIC-study).
    Skou ST; Roos EM; Laursen MB; Rathleff MS; Arendt-Nielsen L; Simonsen OH; Rasmussen S
    BMC Musculoskelet Disord; 2012 May; 13():67. PubMed ID: 22571284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.